InCeRT Implants for Chemo-radiation therapy
InCeRT spacer implants are drug-releasing implants for local chemo- and chemoradiation therapy for a variety of cancers.
We are currently pursuing manufacturing and approval of IND application for a Phase I clinical trial.
Breakthrough technology for Quantitative MRI
Uses magnetic nanoparticles that are safe
Currently conducting first-in-human clinical trial at MGH
Quantitative blood volume measurements for disease diagnosis
Angiograms with unprecedented clarity and definition
Nanomedicines of molecular inhibitors
NanoTalazoparib is a novel nanoparticle formulation of the PARP inhibitor Talazoparib that is being tested in pre-clinical studies in ovarian, breast and lung cancer and Ewings sarcoma animal models, and is ready for scale-up pharmaceutical manufacturing for IND enabling studies.